Reshape Lifesciences Inc. buy krebskrebs
Start price
27.06.23
/
50%
€1.28
Target price
27.06.24
€2.00
Performance (%)
-91.52%
Price
09.02.24
€4.93
Summary
This prediction is currently active. Massive losses of -91.52% have been the result for the BUY prediction by krebskrebs. This prediction currently runs until 27.06.24. The prediction end date can be changed by krebskrebs at any time. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Reshape Lifesciences Inc. | - | - |
iShares Core DAX® | -0.992% | -3.231% |
iShares Nasdaq 100 | -0.225% | -3.339% |
iShares Nikkei 225® | -0.736% | -7.859% |
iShares S&P 500 | -0.509% | -2.979% |
Comments by krebskrebs for this prediction
In the thread Reshape Lifesciences Inc. diskutieren
Buy mit Kursziel 2,0